XARELTO (Rivaroxaban) is an anticoagulant medication (blood thinner) used to reduce the risk of stroke and blood clots in people who have a medical condition called atrial fibrillation that is not caused by a heart valve problem. With atrial fibrillation, part of the heart does not beat the way it should. Rivaroxaban was patented in 2007 and approved for medical use in the United States in 2011. In 2018 it was the 100th most commonly prescribed medication in the United States.
- Reduce the risk of stroke and blood clots in people who have a medical condition called atrial fibrillation that is not caused by a heart valve problem. With atrial fibrillation, part of the heart does not beat the way it should. This can lead to the formation of blood clots, which can travel to the brain, causing a stroke, or to other parts of the body.
- Treat blood clots in the veins of your legs (deep vein thrombosis or DVT) or lungs (pulmonary embolism or PE).
- Reduce the risk of blood clots happening again in people who continue to be at risk for DVT or PE after receiving treatment for blood clots for at least 6 months.
- Help prevent a blood clot in the legs and lungs of people who have just had hip or knee replacement surgery.
- Help prevent blood clots in certain people hospitalized for an acute illness and after discharge, who are at risk of getting blood clots because of the loss of or decreased ability to move around (mobility) and other risks for getting blood clots, and who do not have a high risk of bleeding.
GUARANTEE & EXPIRY DAY
100% original from the German Bayer AG. Expiry date up to 06.2024.
Xarelto is used to treat or prevent blood clots (venous thromboembolism, or VTE). Blood clots can occur in the legs (deep vein thrombosis, DVT) or the lungs (pulmonary embolism, PE). Blood clots can develop when you are very ill and cannot move around as much as normal, such as during or after a stay in the hospital. Blood clots may also develop after knee or hip replacement surgery. Xarelto is also given together with aspirin to lower the risk of stroke, heart attack, or other serious heart problems in people with coronary artery disease (decreased blood flow to the heart) or peripheral artery disease (decreased blood flow to the legs).
PACKAGE & DOSAGE
The medication is taken orally during meals.
Active ingredient: rivaroxaban micronized 15 or 20 mg.
Excipients: microcrystalline cellulose - 37.50 mg, croscarmellose sodium - 3.00 mg, hypromellose 5cP - 3.00 mg, lactose monohydrate - 25.40 mg, magnesium stearate - 0.60 mg, sodium lauryl sulfate - 0.50 mg; shell: iron oxide red - 0.150 mg or 0.350 mg, hypromellose 15cP - 1.50 mg, macrogol 3350 - 0.50 mg, titanium dioxide - 0.350 mg.
You must consult your doctor on the correct dosage and regime for your case. Do not stop taking Xarelto without first talking to your doctor. Stopping suddenly can increase your risk of blood clot or stroke.
The recommended dose is 20 mg once a day. For patients with impaired renal function, the recommended dose is 15 mg once a day. The recommended maximum daily dose is 20 mg.
Duration of treatment: therapy with Xarelto should be considered as a long-term treatment, as long as the benefits of treatment outweigh the risk of potential complications.
WARNINGS AND SIDE EFFECTS
Please see drugs.com/xarelto.html
It is recommended to store the medicine in a dark place at a temperature not exceeding 25°C.
Ask us any questions about Xarelto.